摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 4-(4-bromo-2-formylphenoxy)butanoate | 356039-74-2

中文名称
——
中文别名
——
英文名称
ethyl 4-(4-bromo-2-formylphenoxy)butanoate
英文别名
Ethyl 4-(4-Bromo-2-formyl phenoxy)butyrate
ethyl 4-(4-bromo-2-formylphenoxy)butanoate化学式
CAS
356039-74-2
化学式
C13H15BrO4
mdl
——
分子量
315.164
InChiKey
CWMBRHNHJMTNOA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    18
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl 4-(4-bromo-2-formylphenoxy)butanoatesodium ethanolate 作用下, 以 乙醇 为溶剂, 反应 1.0h, 以34%的产率得到ethyl 7-bromo-2,3-dihydro-1-benzoxepine-4-carboxylate
    参考文献:
    名称:
    Efficient Preparation of Medium Ring Oxygen Heterocycles
    摘要:
    We achieved efficient preparation of medium ring oxygen heterocycles (1), 1-benzoxepines and 1-benzoxocines, by applying intramolecular Claisen-type condensation in dialkyl carbonate with metal alcoholate. Furthermore, we accomplished the preparation of 2,3-dihydro-l-benzoxepin-4-carboxylate intermediate (1e) for orally active CCR5 antagonists by this method.
    DOI:
    10.3987/com-06-10941
  • 作为产物:
    描述:
    4-溴丁酸乙酯5-溴水杨醛potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 1.0h, 以98%的产率得到ethyl 4-(4-bromo-2-formylphenoxy)butanoate
    参考文献:
    名称:
    Efficient Preparation of Medium Ring Oxygen Heterocycles
    摘要:
    We achieved efficient preparation of medium ring oxygen heterocycles (1), 1-benzoxepines and 1-benzoxocines, by applying intramolecular Claisen-type condensation in dialkyl carbonate with metal alcoholate. Furthermore, we accomplished the preparation of 2,3-dihydro-l-benzoxepin-4-carboxylate intermediate (1e) for orally active CCR5 antagonists by this method.
    DOI:
    10.3987/com-06-10941
点击查看最新优质反应信息

文献信息

  • Process for producing cyclic compound
    申请人:——
    公开号:US20030040632A1
    公开(公告)日:2003-02-27
    A process suitable for safely mass-producing, through a short step, cyclic compounds useful in medicines, agricultural chemicals, foods, cosmetics, and chemical products or as intermediates therefor. The process, which is for producing a compound represented by the formula: 1 {wherein Z represents an electron-attracting group; W represents optionally substituted ethylene or optionally substituted vinylene; R 3 represents hydrogen or an optionally substituted hydrocarbon group; and X represents a divalent group [provided that when W represents optionally substituted vinylene, then —X—CH 2 —Z is not —X 1 —X 2 —CH 2 —Z (wherein X 1 represents sulfur or optionally substituted nitrogen and X 2 represents optionally substituted ethylene)]} or a salt thereof, is characterized by subjecting a compound represented by the formula (II) or a salt thereof: 2 (wherein the symbols have the same meanings as the above) to a ring closure reaction in a solvent containing a carbonic diester.
    一种适用于安全批量生产用于药品、农药、食品、化妆品和化学产品或其中间体的环状化合物的过程,通过简短步骤。该过程用于生产由以下公式表示的化合物: 1 (其中Z代表一个吸电子基团;W代表可选择取代的乙烯或可选择取代的乙烯基;R 3 代表氢或可选择取代的碳氢基团;X代表二价基团[但当W代表可选择取代的乙烯基时,那么—X—CH 2 —Z不是—X 1 —X 2 —CH 2 —Z(其中X 1 代表硫或可选择取代的氮,X 2 代表可选择取代的乙烯基)]或其盐,其特征在于将由以下公式(II)或其盐表示的化合物: 2 (其中符号具有与上述相同的含义)置于含有碳酸二酯的溶剂中进行环闭合反应。
  • PROCESS FOR PRODUCING CYCLIC COMPOUND
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP1266881A1
    公开(公告)日:2002-12-18
    A process suitable for safely mass-producing, through a short step, cyclic compounds useful in medicines, agricultural chemicals, foods, cosmetics, and chemical products or as intermediates therefor. The process, which is for producing a compound represented by the formula: wherein Z represents an electron-attracting group; W represents optionally substituted ethylene or optionally substituted vinylene; R3 represents hydrogen or an optionally substituted hydrocarbon group; and X represents a divalent group [provided that when W represents optionally substituted vinylene, then -X-CH2 -Z is not -X1 -X2 -CH2 -Z (wherein X1 represents sulfur or optionally substituted nitrogen and X2 represents optionally substituted ethylene)]} or a salt thereof, is characterized by subjecting a compound represented by the formula (II) or a salt thereof: (wherein the symbols have the same meanings as the above) to a ring closure reaction in a solvent containing a carbonic diester.
    一种适用于通过短步骤安全地大量生产用于医药、农药、食品、化妆品和化学产品或其中间体的环状化合物的工艺。该工艺用于生产由式表示的化合物: 其中 Z 代表引电子基团;W 代表任选取代的乙烯或任选取代的乙烯基;R3 代表氢或任选取代的烃基;X 代表二价基团[但当 W 代表任选取代的乙烯时,则 -X-CH2 -Z 不是 -X1 -X2 -CH2 -Z(其中 X1 代表硫或任选取代的氮,X2 代表任选取代的乙烯)]}或其盐,其特征在于将式(II)代表的化合物或其盐: (其中符号的含义与上述相同)在含有碳酸二酯的溶剂中进行闭环反应。
  • US6864367B2
    申请人:——
    公开号:US6864367B2
    公开(公告)日:2005-03-08
  • US7038042B2
    申请人:——
    公开号:US7038042B2
    公开(公告)日:2006-05-02
  • Efficient Preparation of Medium Ring Oxygen Heterocycles
    作者:Atsuko Nishiguchi、Tomomi Ikemoto、Tatsuya Ito、Shotaro Miura、Kiminori Tomimatsu
    DOI:10.3987/com-06-10941
    日期:——
    We achieved efficient preparation of medium ring oxygen heterocycles (1), 1-benzoxepines and 1-benzoxocines, by applying intramolecular Claisen-type condensation in dialkyl carbonate with metal alcoholate. Furthermore, we accomplished the preparation of 2,3-dihydro-l-benzoxepin-4-carboxylate intermediate (1e) for orally active CCR5 antagonists by this method.
查看更多